Bandaram Pharma Packtech Limited (BOM:524602)
India · Delayed Price · Currency is INR 17.98
+0.64 (3.69%)
At close: Aug 21, 2026
Bandaram Pharma Packtech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 787.72 | 629.23 | 369.64 | 340.79 | 187.32 | - |
Other Revenue | 0 | - | 0 | 0 | - | - |
| 787.72 | 629.23 | 369.64 | 340.79 | 187.32 | - | |
Revenue Growth | 133.74% | 70.23% | 8.46% | 81.93% | - | - |
Cost of Revenue | 681.92 | 538.53 | 296.5 | 275.54 | 160.48 | - |
Gross Profit | 105.8 | 90.7 | 73.14 | 65.25 | 26.84 | - |
Selling, General & Admin | 40.92 | 39.07 | 33.96 | 30.43 | 7.96 | - |
Other Operating Expenses | 26.53 | 22.43 | 10.02 | 6.35 | 5.51 | 0.1 |
Operating Expenses | 77.88 | 71.23 | 50.11 | 44.06 | 19.32 | 0.1 |
Operating Income | 27.93 | 19.47 | 23.03 | 21.19 | 7.52 | -0.1 |
Interest Expense | -14.62 | -15.06 | -8.08 | -6.14 | -3.45 | -0 |
Interest & Investment Income | - | - | - | 0.02 | 0.03 | - |
Currency Exchange Gain (Loss) | - | - | - | - | 0.03 | - |
Other Non Operating Income (Expenses) | - | - | -1.79 | -3.2 | -0.87 | - |
EBT Excluding Unusual Items | 13.31 | 4.41 | 13.16 | 11.87 | 3.26 | -0.1 |
Pretax Income | 13.31 | 4.41 | 13.16 | 11.87 | 3.26 | -0.1 |
Income Tax Expense | 2.23 | -0.07 | 3.22 | 2.39 | 0.68 | - |
Net Income | 11.08 | 4.48 | 9.94 | 9.48 | 2.58 | -0.1 |
Net Income to Common | 11.08 | 4.48 | 9.94 | 9.48 | 2.58 | -0.1 |
Net Income Growth | 31.85% | -54.91% | 4.86% | 268.04% | - | - |
Shares Outstanding (Basic) | 30 | 18 | 12 | 12 | 3 | 3 |
Shares Outstanding (Diluted) | 30 | 18 | 12 | 12 | 3 | 3 |
Shares Change | - | 49.37% | - | 300.00% | - | 31.75% |
EPS (Basic) | 0.36 | 0.25 | 0.83 | 0.79 | 0.86 | -0.03 |
EPS (Diluted) | 0.36 | 0.25 | 0.83 | 0.79 | 0.86 | -0.03 |
EPS Growth | - | -69.81% | 4.86% | -7.99% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -49.23 | -50.12 | -43.09 | -38.94 | 29.15 |
Free Cash Flow Per Share | - | -2.75 | -4.18 | -3.59 | -12.98 | 9.72 |
Dividend Per Share | - | - | 0.100 | 0.100 | 0.100 | - |
Dividend Growth | - | - | 0% | 0% | - | - |
Gross Margin | 13.43% | 14.41% | 19.79% | 19.15% | 14.33% | - |
Operating Margin | 3.55% | 3.09% | 6.23% | 6.22% | 4.01% | - |
Profit Margin | 1.41% | 0.71% | 2.69% | 2.78% | 1.38% | - |
Free Cash Flow Margin | - | -7.82% | -13.56% | -12.64% | -20.79% | - |
EBITDA | 38.57 | 29.21 | 29.16 | 28.33 | 13.32 | 0.08 |
EBITDA Margin | 4.90% | 4.64% | 7.89% | 8.31% | 7.11% | - |
D&A For EBITDA | 10.64 | 9.74 | 6.13 | 7.14 | 5.8 | 0.18 |
EBIT | 27.93 | 19.47 | 23.03 | 21.19 | 7.52 | -0.1 |
EBIT Margin | 3.55% | 3.09% | 6.23% | 6.22% | 4.01% | - |
Effective Tax Rate | 16.75% | - | 24.48% | 20.13% | 20.91% | - |
Revenue as Reported | 787.9 | 629.41 | 370.58 | 341.12 | 189.22 | - |
Advertising Expenses | - | - | 0.24 | 0.15 | 0.37 | - |